Literature DB >> 8712766

Pulmonary complications of HIV infection.

J F Murray1.   

Abstract

Pulmonary disease is a major source of morbidity and mortality in HIV-infected persons. Pneumocystis carinii pneumonia has decreased substantially during the last eight years, but in the United States it remains the most common disorder that announces the onset of AIDS. In contrast, tuberculosis is by far the most important AIDS-associated indicator disease in developing countries. Community-acquired acute bacterial pneumonia is a common HIV-linked complication throughout the world; pneumonia occurs at all levels of immune suppression but increases in frequency as CD4 counts decrease. Fungal infections mainly afflict persons who live or have lived in the various endemic areas. AIDS-related Kaposi's sarcoma and lymphoma generally do not involve the lungs until the malignancies are advanced. The increasing use of successful chemoprophylaxis against many important HIV-associated infections is increasing the incidence of other end-stage complications such as cytomegalovirus and disseminated MAC disease.

Entities:  

Mesh:

Year:  1996        PMID: 8712766     DOI: 10.1146/annurev.med.47.1.117

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  5 in total

1.  High prevalence of asthma in HIV-infected adults: new insights.

Authors:  William T Shearer; David B Corry
Journal:  J Allergy Clin Immunol       Date:  2012-01-31       Impact factor: 10.793

2.  Simplified sample processing combined with a sensitive one-tube nested PCR assay for detection of Pneumocystis carinii in respiratory specimens.

Authors:  A Mathis; R Weber; H Kuster; R Speich
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

3.  Absence of the macrophage mannose receptor in mice does not increase susceptibility to Pneumocystis carinii infection in vivo.

Authors:  Steve D Swain; Sena J Lee; Michel C Nussenzweig; Allen G Harmsen
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

4.  Strong mucosal immune responses in SIV infected macaques contribute to viral control and preserved CD4+ T-cell levels in blood and mucosal tissues.

Authors:  Tina Schultheiss; Reiner Schulte; Ulrike Sauermann; Wiebke Ibing; Christiane Stahl-Hennig
Journal:  Retrovirology       Date:  2011-04-11       Impact factor: 4.602

5.  Expression of pIgR in the tracheal mucosa of SHIV/SIV-infected rhesus macaques.

Authors:  Dong Li; Feng-Jie Wang; Lei Yu; Wen-Rong Yao; Yan-Fang Cui; Gui-Bo Yang
Journal:  Zool Res       Date:  2017-01-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.